News + Filings Transactions Holdings
All 13F 13D/G Other
|
SIDRANSKY DAVID
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/17/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 11,480 options to buy
@ $7, valued at
$80.4k
|
|
01/23/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/23/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.
Txns:
| Granted 46 shares
@ $0 Granted 2,342 options
@ $55.23, valued at
$129.3k
Granted 2,342 options
@ $8.7, valued at
$20.4k
|
|
12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/14/2022 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Paid exercise price by delivering 3,562 shares
@ $7.51, valued at
$26.8k
Exercised 8,333 options to buy
@ $3.21, valued at
$26.7k
|
|
06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/09/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 8,045 options to buy
@ $10.1, valued at
$81.3k
|
|
10/19/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Exercised 16,667 shares
@ $1.59, valued at
$26.5k
Paid exercise price by delivering 2,629 shares
@ $10.08, valued at
$26.5k
Granted 16,667 options to buy
@ $1.59, valued at
$26.5k
|
|
06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/08/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.
Txns:
| Bought 200 shares
@ $15.27, valued at
$3.1k
Bought 25 shares
@ $15.02, valued at
$375.5 Bought 1 shares
@ $9.6, valued at
$9.6 Bought 4 shares
@ $11.86, valued at
$47.4 Bought 5 shares
@ $11.07, valued at
$55.4 Bought 10 shares
@ $10.07, valued at
$100.7 Bought 1 shares
@ $10.7, valued at
$10.7 Bought 4 shares
@ $11.56, valued at
$46.2 |
|
01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 8,333 options to buy
@ $11.96, valued at
$99.7k
|
|
10/28/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Paid exercise price by delivering 10,100 shares
@ $9.01, valued at
$91k
Exercised 16,667 options to buy
@ $5.46, valued at
$91k
|
|
05/05/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 13,000 options
@ $0.66, valued at
$8.6k
|
|
03/20/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Orgenesis Inc.
Txns:
| Granted 12,500 options
@ $2.99, valued at
$37.4k
|
|
01/16/2020 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Orgenesis Inc.
Txns:
| Granted 12,500 options
@ $2.99, valued at
$37.4k
|
|
11/06/2019 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 8,333 options to buy
@ $5.43, valued at
$45.2k
|
|
10/25/2019 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 10,000 options
@ $0.31, valued at
$3.1k
|
|
03/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/07/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 30,000 options
@ $0.54, valued at
$16.2k
|
|
11/05/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 8,333 options to buy
@ $12.73, valued at
$106.1k
|
|
10/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/25/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 15,000 shares
@ $0 |
|
06/14/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 5,000 shares
@ $1.71, valued at
$8.6k
|
|
06/13/2018 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 3,198 shares
@ $1.85, valued at
$5.9k
Granted 6,802 shares
@ $1.84, valued at
$12.5k
|
|
11/06/2017 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 30,000 options
@ $3.19, valued at
$95.7k
|
|
11/03/2016 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 16,667 options
@ $1.59, valued at
$26.5k
|
|
08/10/2016 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Sold 11,404 shares
@ $15.17, valued at
$173k
Sold 11,404 shares
@ $14.85, valued at
$169.3k
|
|
11/06/2015 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 2,744 shares
@ $0 Granted 50,000 options
@ $12.81, valued at
$640.5k
|
|
11/04/2015 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on CHAMPIONS ONCOLOGY, INC.
Txns:
| Granted 16,667 options
@ $5.46, valued at
$91k
|
|
04/01/2015 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 15,000 shares
@ $0 Granted 20,000 options
@ $13.44, valued at
$268.8k
|
|
02/04/2015 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Advaxis, Inc.
Txns:
| Granted 25,115 shares
@ $0 |
|
01/12/2015 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on IMMUNE PHARMACEUTICALS INC
Txns:
| Granted 3,409 restricted stock units
@ $0 Granted 50,000 options
@ $2.2, valued at
$110k
|
|
|
|
|